Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.55 |
| ▸ | TAS2R46 | P59540 | 9/20 | 0.40 |
| ▸ | TAS2R31 | P59538 | 2/20 | 0.40 |
| ▸ | TAS2R10 | Q9NYW0 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Desacetoxymatricarin SCHEMBL14190533 | 1.00 | CYP1A2 (1.00) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| Desacetoxymatricarin SCHEMBL14029298 | 1.00 | CYP1A2 (1.00) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| Desacetoxymatricarin SCHEMBL3458919 | 1.00 | CYP1A2 (1.00) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL14215976 | 0.83 | CYP1A2 (0.71) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL7817610 | 0.74 | CYP1A2 (0.59) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| Austricin SCHEMBL14029373 | 0.73 | CYP1A2 (0.97) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| Austricin SCHEMBL4735162 | 0.73 | CYP1A2 (0.97) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| Austricin SCHEMBL14190527 | 0.73 | CYP1A2 (0.97) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| Dehydroleucodin SCHEMBL4998391 | 0.71 | CYP19A1 (1.00) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL14533824 | 0.69 | CYP1A2 (0.52) | CYP1A2ALDH1A1MEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117241773-A | Polymer medicine bottle with standard external dimensions and reduced internal volume | SIO2医疗产品有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-118742318-A | Peritoneal dialysis fluid composition comprising complement inhibitor | 因维齐乌斯有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118725810-A | Active energy ray-curable adhesive composition, cured product, and adhesive sheet | 荒川化学工业株式会社 | 2024-10-01 | — | — | CN | disclosed |
| CN-113195541-B | Antibodies to PMEL17 and conjugates thereof | 诺华股份有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-117241773-A | Polymer medicine bottle with standard external dimensions and reduced internal volume | SIO2医疗产品有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-116940689-A | Method for producing Cas3 protein | Ｃ４Ｕ株式会社 | 2023-10-24 | — | — | CN | disclosed |
| CN-116687900-A | Application of small molecular compound Z56957173 in preparation of medicine for treating diseases related to nerve axon injury | 南通大学 | 2023-09-05 | — | — | CN | disclosed |
| CN-116003592-A | Antibodies to human thrombopoietin | 株式会社医学生物学研究所 | 2023-04-25 | — | — | CN | disclosed |
| CN-107129478-B | Semi-terpene lactone compound and preparation method and application thereof | 延边大学 | 2021-10-26 | — | — | CN | disclosed |
| CN-107129478-B | Semi-terpene lactone compound and preparation method and application thereof | 延边大学 | 2021-10-26 | — | — | CN | disclosed |
| US-20070300327-A1 | Plant enzymes for bioconversion | PLANT RESEARCH INTERNATIONAL B.V. | 2007-12-27 | — | — | US | disclosed |
| EP-1542682-A4 | NOVEL INHIBITORS OF UBIQUITIN ISOPEPTIDASES | UNIV UTAH RES FOUND (US) | 2007-10-31 | — | — | EP | disclosed |
| US-7214507-B2 | Plant enzymes for bioconversion | PLANT RESEARCH INTERNATIONAL B.V. (NL) | 2007-05-08 | — | — | US | disclosed |
| US-20060106099-A1 | Novel inhibitors of ubiquitin isopeptidases | UNIVERSITY OF UTAH | 2006-05-18 | — | — | US | disclosed |
| EP-1542682-A2 | NOVEL INHIBITORS OF UBIQUITIN ISOPEPTIDASES | University of Utah Research Foundation (US) | 2005-06-22 | — | — | EP | disclosed |
| CN-1589327-A | Plant enzymes for bioconversion | PLANT RES INT BV (NL) | 2005-03-02 | — | — | CN | disclosed |
| US-20050019882-A1 | Using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates; terpenoid biosynthesis | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2005-01-27 | — | — | US | disclosed |
| WO-2004009023-A2 | NOVEL INHIBITORS OF UBIQUITIN ISOPEPTIDASES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2004-01-29 | — | — | WO | disclosed |
| US-5663196-A | ADMINISTERING A SESQUITERPENE LACTONE TO AN ANIMAL | BOSTON UNIVERSITY (US) | 1997-09-02 | — | — | US | disclosed |
| WO-1995006476-A1 | METHODS AND COMPOSITIONS FOR TREATING NEOPLASTIC DISORDERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1995-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106099-A1 | Novel inhibitors of ubiquitin isopeptidases | TP53, MDM2, UCHL1 | CYP1A2 3036/4885ALDH1A1 391/4885MEN1 4347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.